Treatment of periorbital rhytids with botulinum toxin type A: Maximizing safety and results

Archives of Facial Plastic Surgery

Volumn 7, Issue 3, 2005, Pages 198-202

  Spiegel, Jeffrey H ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

CUTANEOUS PARAMETERS; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; ESTHETIC SURGERY; EYE; FEMALE; FOLLOW UP; HUMAN; MALE; REJUVENATION; REVIEW; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EYE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; REJUVENATION; RISK ASSESSMENT; SKIN AGING; TREATMENT OUTCOME;

EID: 23044456390     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfaci.7.3.198     Document Type: Article

References (21)

1. American Academy of Facial Plastic and Reconstructive Surgery. 2002 Membership survey: trends in facial plastic surgery [news release]. Alexandria, Va: American Academy of Facial Plastic and Reconstructive Surgery; April 2003.
2. US Food and Drug Administration. FDA Consumer Magazine. July-August 2002.
3. Hauser RA, Wahba M. Botulinum toxin type A injections. Available at: www .emedicine.com/plastic/topic509.htm. Accessed November 26, 2004.
4. Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blinded, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46:840-849.
5. Paloma V, Samper A. A complication with aesthetic use of botulinum toxin type A: herniation of the orbital fat. Plast Reconstr Surg. 2001;107:1315.
6. Matarasso SL. Decreased tear expression with an abnormal Schirmer's test following botulinum toxin type A for the treatment of lateral canthal rhytides. Dermatol Surg. 2002;28:149-152.
7. Ahn MS, Catten M, Maas CS. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg. 2000;105:1129-1135.
8. Frankel AS, Kamer FM. Chemical browlift. Arch Otolaryngol Head Neck Surg. 1998; 124:321-323.
9. Zesiewicz TA, Stamey W, Sullivan KL, Hauser RA. Botulinum toxin A for the treatment of cervical dystonia. Expert Opin Pharmacother. 2004;5:2017-2024.
10. Spiegel JH, Derosa J. The atomic relationship between the obicularis oculi muscle and the levator labii superioris and zygomaticus muscle complexes. Plast Reconstr Surg. In press.
11. Matarasso SL, Matarasso A. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg. 2001;108:208-214.
12. Fagien S. Discussion: treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptsosis following injections to the lateral canthal rhytids by Seth L. Matarasso, M.D., and Alan Matarasso, M.D. Plast Reconstr Surg. 2001;108:215-217.
13. Tang-Liu DD, Aoki KR, Dolly JO, et al. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon. 2003;42:461-469.
14. Niamtu J III. Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments. J Oral Maxillofac Surg. 2003;61:317-324.
15. Borodic GE, Ferrante R, Pearce LB, et al. Pharmacology and histology of the therapeutic application of botulinum toxin. In: Janckovic J, Hallett M, eds. Therapy With Botulinum Toxin. New York, NY: Marcel-Dekker: 1994:119-157.
16. Carruthers J, Fagien S, Matarasso SL; Botulinum Toxin Type A Consensus Group. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114(6 suppl):1S-22S.
17. Shaari CM, George E, Wu BL, Biller HF, Sanders I. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope. 1991;101:960-964.
18. Carruthers JD, Carruthers A. Botulinum toxin in clinical ophthalmology. Can J Ophthalmol. 1996;31:389-400.
19. Macdonald MR, Spiegel JH, Raven RB, Kabaker SS, Maas CS. An anatomical approach to glabellar rhytids. Arch Otolaryngol Head Neck Surg. 1998;124:1315-1320.
20. Gassner HG, Sherris DA. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study. Mayo Clin Proc. 2000;75:701-704.
21. Redaelli A, Forte R. Botulinum toxin dilution: our technique. J Cosmet Laser Ther. 2003;5:218-219.